Total Receivables - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Total Receivables Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Total Receivables
â‚Ş201.5m
CAGR 3-Years
132%
CAGR 5-Years
174%
CAGR 10-Years
76%
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Total Receivables
$3.8B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
Redhill Biopharma Ltd
NASDAQ:RDHL
Total Receivables
$974k
CAGR 3-Years
-68%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Sol Gel Technologies Ltd
NASDAQ:SLGL
Total Receivables
$6.1m
CAGR 3-Years
85%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Total Receivables
$4.9m
CAGR 3-Years
18%
CAGR 5-Years
1%
CAGR 10-Years
7%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Total Receivables
â‚Ş139m
CAGR 3-Years
17%
CAGR 5-Years
11%
CAGR 10-Years
3%

See Also

What is InterCure Ltd's Total Receivables?
Total Receivables
201.5m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Total Receivables amounts to 201.5m ILS.

What is InterCure Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
76%

Over the last year, the Total Receivables growth was 50%. The average annual Total Receivables growth rates for InterCure Ltd have been 132% over the past three years , 174% over the past five years , and 76% over the past ten years .

Back to Top